Zdrowie i gospodarka · 19/05/2025

FDA to Host Public Meeting on Reauthorization of Generic Drug User Fee Amendments

The FDA is hosting a public meeting to gather public input on the reauthorization of the Generic Drug User Fee Amendments (GDUFA) for fiscal years 2028 to 2032, with a public meeting scheduled to take place and written comments to be accepted.